TELA Bio, Inc.
TELA
$1.85
-$0.0927-4.78%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 18.52M | 17.65M | 18.96M | 16.09M | 16.60M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 18.52M | 17.65M | 18.96M | 16.09M | 16.60M |
| Cost of Revenue | 5.91M | 6.33M | 6.00M | 4.92M | 5.17M |
| Gross Profit | 12.61M | 11.32M | 12.95M | 11.17M | 11.43M |
| SG&A Expenses | 20.44M | 17.55M | 20.16M | 20.32M | 21.35M |
| Depreciation & Amortization | 95.00K | 95.00K | 95.00K | 95.00K | 95.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 28.99M | 26.00M | 28.32M | 27.66M | 29.01M |
| Operating Income | -10.47M | -8.35M | -9.37M | -11.57M | -12.41M |
| Income Before Tax | -11.21M | -9.35M | -10.37M | -12.60M | -5.66M |
| Income Tax Expenses | 52.00K | -144.00K | -- | -- | -- |
| Earnings from Continuing Operations | -11.26M | -9.21M | -10.37M | -12.60M | -5.66M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -11.26M | -9.21M | -10.37M | -12.60M | -5.66M |
| EBIT | -10.47M | -8.35M | -9.37M | -11.57M | -12.41M |
| EBITDA | -10.21M | -8.09M | -9.10M | -11.32M | -12.17M |
| EPS Basic | -0.25 | -0.23 | -0.42 | -0.51 | -0.23 |
| Normalized Basic EPS | -0.15 | -0.15 | -0.26 | -0.32 | -0.34 |
| EPS Diluted | -0.25 | -0.23 | -0.42 | -0.51 | -0.23 |
| Normalized Diluted EPS | -0.15 | -0.15 | -0.26 | -0.32 | -0.34 |
| Average Basic Shares Outstanding | 45.27M | 40.07M | 24.70M | 24.66M | 24.58M |
| Average Diluted Shares Outstanding | 45.27M | 40.07M | 24.70M | 24.66M | 24.58M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |